Allogeneic RPE cell suspension manufactured at scale demonstrating preclinical safety and efficacy led to IND approval.
大规模生产的同种异体 RPE 细胞悬液证明了其临床前安全性和有效性，从而获得了 IND 批准
期刊:npj Regenerative Medicine
影响因子:6.5
doi:10.1038/s41536-025-00407-0
Soundararajan Lalitha, Surendran Harshini, Patlolla Niharika, Battu Rajani, Stoddard Jonathan, Arrizabalaga Sebastian, Liu Zengping, Lingam Gopal, Su Xinyi, Ryals Renee C, Pal Rajarshi
